Yanling Wang

1.6k total citations
39 papers, 1.1k citations indexed

About

Yanling Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yanling Wang has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Yanling Wang's work include Pancreatic and Hepatic Oncology Research (7 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Yanling Wang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Yanling Wang collaborates with scholars based in China, United States and Croatia. Yanling Wang's co-authors include Mengting Tong, Charlie Xiang, Samuel J. Pleasure, Amelia Stanco, Gregory B. Potter, John L.R. Rubenstein, Jason E. Long, Guangnan Li, Timothy W. Behrens and Da Li and has published in prestigious journals such as Neuron, Nature Immunology and Applied and Environmental Microbiology.

In The Last Decade

Yanling Wang

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanling Wang China 16 397 349 282 140 126 39 1.1k
Tae-Hee Lee South Korea 16 645 1.6× 417 1.2× 212 0.8× 191 1.4× 145 1.2× 62 1.4k
Victor H. Guaiquil United States 21 519 1.3× 145 0.4× 137 0.5× 63 0.5× 91 0.7× 48 1.5k
Lin Zhong China 22 578 1.5× 181 0.5× 159 0.6× 120 0.9× 267 2.1× 72 1.5k
Chao Sheng China 20 582 1.5× 172 0.5× 81 0.3× 290 2.1× 95 0.8× 64 1.2k
Mariya Farooqui United States 20 494 1.2× 202 0.6× 101 0.4× 99 0.7× 102 0.8× 32 998
Aru Narendran Canada 25 908 2.3× 516 1.5× 195 0.7× 149 1.1× 58 0.5× 115 1.7k
Annalisa Camporeale Italy 21 617 1.6× 389 1.1× 466 1.7× 92 0.7× 51 0.4× 28 1.4k
Xiaoli Hu China 18 261 0.7× 198 0.6× 174 0.6× 100 0.7× 163 1.3× 69 1.0k
Doris Kloor Germany 19 476 1.2× 104 0.3× 158 0.6× 73 0.5× 119 0.9× 35 1.2k
Xiya Yu China 15 557 1.4× 266 0.8× 151 0.5× 94 0.7× 92 0.7× 26 1.1k

Countries citing papers authored by Yanling Wang

Since Specialization
Citations

This map shows the geographic impact of Yanling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanling Wang more than expected).

Fields of papers citing papers by Yanling Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanling Wang. The network helps show where Yanling Wang may publish in the future.

Co-authorship network of co-authors of Yanling Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanling Wang. A scholar is included among the top collaborators of Yanling Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanling Wang. Yanling Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Deng, Lei, Bo Peng, Yong Zhao, et al.. (2025). Predicting tumor response to TACE plus lenvatinib and PD-1 inhibitors for unresectable HCC: A multicenter observational study. European Journal of Radiology. 192. 112401–112401.
3.
Wang, Tao, Yanling Wang, Jinjing Zhang, & Yushi Yao. (2024). Role of trained innate immunity against mucosal cancer. Current Opinion in Virology. 64. 101387–101387. 2 indexed citations
4.
Wang, Tao, Yanling Wang, & Yushi Yao. (2024). Gut microbe guides alveolar macrophages to fight flu. Cell Host & Microbe. 32(3). 296–298. 3 indexed citations
5.
Wang, Yanling, et al.. (2024). Thyroid dysfunction (TD) induced by PD-1/PD-L1 inhibitors in advanced lung cancer. Heliyon. 10(5). e27077–e27077. 2 indexed citations
6.
Wang, Tao, et al.. (2023). Influenza-trained mucosal-resident alveolar macrophages confer long-term antitumor immunity in the lungs. Nature Immunology. 24(3). 423–438. 98 indexed citations
7.
Zong, Lanlan, Yanling Wang, Shiyu Song, et al.. (2023). Formulation and Evaluation on Synergetic Anti-Hepatoma Effect of a Chemically Stable and Release-Controlled Nanoself-Assembly with Natural Monomers. International Journal of Nanomedicine. Volume 18. 3407–3428. 7 indexed citations
8.
Ge, Weiyu, Yue Ming, Tianhao Zhou, et al.. (2023). PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells. Cancer Letters. 558. 216095–216095. 44 indexed citations
9.
Ge, Weiyu, Kexuan Wang, Tiebo Mao, et al.. (2022). Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma. Frontiers in Cell and Developmental Biology. 10. 942225–942225. 6 indexed citations
10.
Ge, Weiyu, Yongchao Wang, Yanling Wang, et al.. (2022). A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer. Frontiers in Cell and Developmental Biology. 10. 1001606–1001606. 3 indexed citations
11.
Wang, Yanling, Wei Liu, Miao Liu, et al.. (2022). Nifuroxazide in combination with CpG ODN exerts greater efficacy against hepatocellular carcinoma. International Immunopharmacology. 108. 108911–108911. 5 indexed citations
12.
Wang, Yanling, Binbin Wu, Xiaoshan Zheng, Baoliang Chen, & Chiheng Chu. (2022). Assessing the quantum yield spectrum of photochemically produced reactive intermediates from black carbon of various sources and properties. Water Research. 229. 119450–119450. 16 indexed citations
13.
Zhang, Haitao, Yongxin Luan, Shisong Jing, et al.. (2020). Baicalein mediates protection against Staphylococcus aureus-induced pneumonia by inhibiting the coagulase activity of vWbp. Biochemical Pharmacology. 178. 114024–114024. 27 indexed citations
14.
Chen, Xin, Yi Wu, Yanling Wang, et al.. (2020). Human menstrual blood-derived stem cells mitigate bleomycin-induced pulmonary fibrosis through anti-apoptosis and anti-inflammatory effects. Stem Cell Research & Therapy. 11(1). 477–477. 43 indexed citations
15.
Tong, Mengting, Jing Wang, Hongliang Zhang, et al.. (2019). Efficacy and safety of gemcitabine plus anti-angiogenesis therapy for advanced pancreatic cancer: a systematic review and meta-analysis of clinical randomized phase III trials. Journal of Cancer. 10(4). 968–978. 11 indexed citations
16.
Tong, Mengting, Jing Wang, Wenting He, et al.. (2018). Predictive biomarkers for tumor immune checkpoint blockade. Cancer Management and Research. Volume 10. 4501–4507. 15 indexed citations
17.
18.
Liu, Bing, Hong Zhang, Xin Duan, et al.. (2009). Adenovirus-Mediated Wild-Type p53 Transfer Radiosensitizes H1299 Cells to Subclinical-Dose Carbon-Ion Irradiation Through the Restoration of p53 Function. Cancer Biotherapy and Radiopharmaceuticals. 24(1). 57–66. 4 indexed citations
19.
Yang, Zhousheng, Yanling Wang, Yunchun Liu, & Guang‐Chao Zhao. (2005). Potential-modulated DNA Cleavage by (N-Salicylideneglycinato)-copper(II) Complex. Analytical Sciences. 21(11). 1355–1358. 5 indexed citations
20.
Yang, Zhousheng, Yanling Wang, & Guang‐Chao Zhao. (2004). The Interaction of Copper-Bipyridyl Complex with DNA and Cleavage to DNA. Analytical Sciences. 20(8). 1127–1130. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026